The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: A Rome Foundation working team literature review

Gut

Volumn 66, Issue 6, 2017, Pages 1075-1082

  Sperber, Ami D ^a   Dumitrascu, Dan ^b   Fukudo, Shin ^c   Gerson, Charles ^d   Ghoshal, Uday C ^e   Gwee, Kok Ann ^f   Hungin, A Pali S ^g   Kang, Jin Yong ^h   Minhu, Chen ⁱ   Schmulson, Max ^j   Bolotin, Arkady ^a   Friger, Michael ^a   Freud, Tamar ^a   Whitehead, William ^k  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^f Dept Medicine Endocrinol Diabet   (Singapore)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h ST GEORGE S HOSPITAL   (United Kingdom)

ⁱ THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^j HOSPITAL GENERAL DE MÉXICO   (Mexico)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

more..

Author keywords

EPIDEMIOLOGY; FUNCTIONAL BOWEL DISORDER; IRRITABLE BOWEL SYNDROME

Indexed keywords

ADULT; AFRICA; ARTICLE; ASIA; AUSTRALIA; COMMUNITY ASSESSMENT; DEMOGRAPHY; DISEASE SURVEILLANCE; EUROPE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; IRAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEXICO; NEW ZEALAND; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; GLOBAL HEALTH; IRRITABLE BOWEL SYNDROME; METHODOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICA; ASIA; AUSTRALIA; EUROPE; GLOBAL HEALTH; HUMANS; IRRITABLE BOWEL SYNDROME; LATIN AMERICA; NEW ZEALAND; PREVALENCE; RESEARCH DESIGN; UNITED STATES;

EID: 84962135383     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-311240     Document Type: Article

References (105)

1. Tan YM, Goh KL, Muhidayah R, et al. Prevalence of irritable bowel syndrome in young adult Malaysians: A survey among medical students. J Gastroenterol Hepatol 2003;18:1412-16.
2. Masud MA, Hasan M, Azad Khan AK. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior. Am J Gastroenterol 2001;96:1547-52.
3. Danivat D, Tankeyoon M, Sriratanaban A. Prevalence of irritable bowel syndrome in a non-Western population. BMJ 1988;296:1710.
4. Bi-Zhen W, Qi-Ying P. Functional bowel disorders in apparently healthy Chinese people. Chin J Epid 1988;9:345-9.
5. Lule GN, Amayo EO. Irritable bowel syndrome in Kenyans. East Afr Med J 2002;79:360-3.
6. Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;3:1155-61.
7. Sperber AD, Shvartzman P, Friger M, et al. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: Are we getting closer to the true prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol 2007;19:441-7.
8. Agréus L. Rome? Manning? Who cares? Am J Gastroenterol 2000;95:2679-81.
9. Morgan D, Martin C, Peña E, et al. Significant differences in Rome II and Rome III determination of FGID prevalence: Population-based assessments in Central America. Gastroenterology 2008;134(Suppl 1):A-418.
10. Sperber AD, Drossman DA, Quigley EM. IBS-The global perspective (a Rome Foundation-WGO symposium). Am J Gastroenterol 2012;107:1602-9.
11. Sperber AD, Gwee K-A, Hungin AP, et al. Conducting Multinational, Cross-cultural Research in the Functional GI Disorders and Fostering Multinational Research Networks. Secondary Conducting Multinational, Cross-cultural Research in the Functional GI Disorders and Fostering Multinational Research Networks. 2014. http://www.romecriteria.org/committees/WorkingTeamFinalReport-Jan2014.pdf
12. Quigley EM, Abdel-Hamid H, Barbara G, et al. A global perspective on irritable bowel syndrome: A consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012;46:35666.
13. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: A meta-Analysis. Clin Gastroenterol Hepatol 2012;10:712-21.e4.
14. Sperber AD. The challenge of cross-cultural, multi-national research: potential benefits in the functional gastrointestinal disorders. Neurogastroenterol Motil 2009;21:351-60.
15. Sperber AD, Gwee KA, Hungin AP, et al. Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report. Aliment Pharmacol Ther 2014;40:1094-102.
16. Yang B. Meta Prevalence Estimates. Generating combined prevalence estimates from separate population surveys: NSW Department of Health, Center for Epidemiology and Research, 2007.
17. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23:1663-82.
18. Lipsey MW, Wilson DB. Practical Meta-Analysis. Thousand Oaks, CA: Sage, 2001.
19. Drug VL, Oprea L, Bunescu L, et al. The epidemiology of the Irritable Bowel Syndrom in urban general population. Rom J Gastroenterol 2000;9:83-6.
20. Ziólkowski BA, Pacholec A, Kudlicka M, et al. Prevalence of abdominal symptoms in the Polish population. Przeglad Gastroenterologiczny 2012;7:20-5.
21. Jeong JJ, Choi MG, Cho YS, et al. Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol 2008;14:6388-94.
22. Kawamura A, Adachi K, Takashima T, et al. Prevalence of irritable bowel syndrome and its relationship with Helicobacter pylori infection in a Japanese population. J Gastroenterol Hepatol 2001;16:384-8.
23. Miwa H. Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria. Patient Prefer Adherence 2008;2:143-7.
24. Lee SY, Lee KJ, Kim SJ, et al. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: A population-based study. Digestion 2009;79:196-201.
25. Hongo M. Epidemiology of FGID symptoms in Japanese general population with reference to life style. J Gastroenterol Hepatol 2011;26(Suppl 3):19-22.
26. Park DW, Lee OY, Shim SG, et al. The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil 2010;16:186-93.
27. Kumano H, Kaiya H, Yoshiuchi K, et al. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol 2004;99:370-6.
28. Yun CH, Lee SK, Kim H, et al. Association between irritable bowel syndrome and restless legs syndrome in the general population. J Sleep Res 2012;21:569-76.
29. Matsuzaki J, Suzuki H, Fukushima Y, et al. High frequency of overlap between functional dyspepsia and overactive bladder. Neurogastroenterol Motil 2012;24:821-7.
30. Han SH, Lee OY, Bae SC, et al. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. J Gastroenterol Hepatol 2006;21:1687-92.
31. Li FX, Patten SB, Hilsden RJ, et al. Irritable bowel syndrome and health-related quality of life: A population-based study in Calgary, Alberta. Can J Gastroenterol 2003;17:259-63.
32. Locke GR III, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005;17:29-34.
33. Perveen I, Hasan M, Masud MA, et al. Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern. Saudi J Gastroenterol 2009;15:239-43.
34. Makharia GK, Verma AK, Amarchand R, et al. Prevalence of irritable bowel syndrome: A community based study from northern India. J Neurogastroenterol Motil 2011;17:82-7.
35. Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001;20:103-6.
36. Husain N, Chaudhry IB, Jafri F, et al. A population-based study of irritable bowel syndrome in a non-Western population. Neurogastroenterol Motil 2008;20:1022-9.
37. Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004;19:1217-24.
38. Zhao Y, Zou D, Wang R, et al. Dyspepsia and irritable bowel syndrome in China: A population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther 2010;32:562-72.
39. Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: A population-based study. Aliment Pharmacol Ther 2002;16:2081-8.
40. Pan G, Lu S, Ke M, et al. Epidemiologic study of the irritable bowel syndrome in Beijing: stratified randomized study by cluster sampling. Chin Med J 2000;113:35-9.
41. Lau EM, Chan FK, Ziea ET, et al. Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci 2002;47:2621-4.
42. Rajendra S, Alahuddin S. Prevalence of irritable bowel syndrome in a multi-ethnic Asian population. Aliment Pharmacol Ther 2004;19:707-14.
43. Zang S, Zhang X, Chen J. Epidemiology of Irritable bowel syndrome in community population. J Comm Med 2007;5:19-20.
44. Chen Y, Liu S, Hao X, et al. Epidemiology study of irritable bowel syndrome in urban and rural population in Luohe China. Chin J Prac Nurs 2011;27:50-3.
45. Shen F, Chen G, Zhou H, et al. Correlation analysis of quality of sleep and irritable bowel syndrome in community population. Chin J Dig 2010;30:525-8.
46. Wu X, Chen J, Li Y, et al. Epidemiology study of irritable bowel syndrome in community population in Jieyang, Guangdong, China. Public Medical Forum Magazine 2007;11:18-19.
47. Fu Y, Li L, Fu Y. Epidemiology of irritable bowel syndrom and functional constipation in community population of Pindingshan China. Chin J Clin Gastro 2005;17:132-43.
48. Gwee KA, Wee S, Wong ML, et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol 2004;99:924-31.
49. Lee S, Wu J, Ma YL, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: A community study. Aliment Pharmacol Ther 2009;30:643-51.
50. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: Are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000;95:3176-83.
51. Zuckerman MJ, Nguyen G, Ho H, et al. A survey of irritable bowel syndrome in Vietnam using the Rome criteria. Dig Dis Sci 2006;51:946-51.
52. Chen LY, Ho KY, Phua KH, Community Medicine GI Study Group. Normal bowel habits and prevalence of functional bowel disorders in Singaporean adults-findings from a community based study in Bishan. Singapore Med J 2000;41:255-8.
53. Aggarwal VR, McBeth J, Zakrzewska JM, et al. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol 2006;35:468-76.
54. Ebling B, Jurcic D, Gmajni R, et al. Anthropological, demographic and socioeconomic characteristics of irritable bowel syndrome. Coll Antropol 2011;35:513-21.
55. Hillilä MT, Färkkilä MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004;20:339-45.
56. Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40, 000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
57. Icks A, Haastert B, Enck P, et al. Prevalence of functional bowel disorders and related health care seeking: A population-based study. Z Gastroenterol 2002;40:177-83.
58. Karaman N, Turkay C, Yonem O. Irritable bowel syndrome prevalence in city center of Sivas. Turk J Gastroenterol 2003;14:128-31.
59. Katsinelos P, Lazaraki G, Kountouras J, et al. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Eur J Gastroenterol Hepatol 2009;21:183-9.
60. Kennedy TM, Jones RH. Epidemiology of cholecystectomy and irritable bowel syndrome in a UK population. Br J Surg 2000;87:1658-63.
61. Agréus L, Svärdsudd K, Talley NJ, et al. Natural history of gastroesophageal reflux disease and functional abdominal disorders: A population-based study. Am J Gastroenterol 2001;96:2905-14.
62. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al. Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria-A 10-year follow-up study. Aliment Pharmacol Ther 2010;32:670-80.
63. Osterberg E, Blomquist L, Krakau I, et al. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol 2000;35:264-8.
64. Papatheodoridis GV, Karamanolis DG. Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population. Scand J Gastroenterol 2005;40:412-21.
65. Usai P, Manca R, Lai MA, et al. Prevalence of irritable bowel syndrome in Italian rural and urban areas. Eur J Intern Med 2010;21:324-6.
66. Vandvik PO, Lydersen S, Farup PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006;41:650-6.
67. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: A community survey. Br J Gen Pract 2004;54:495-502.
68. Baretic M, Bilic A, Jurcic D, et al. Epidemiology of irritable bowel syndrome in Croatia. Coll Antropol 2002;26(Suppl):85-91.
69. Boekema PJ, van Dam van Isselt EF, Bots ML, et al. Functional bowel symptoms in a general Dutch population and associations with common stimulants. Neth J Med 2001;59:23-30.
70. Bommelaer G, Dorval E, Denis P, et al. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol 2002;26:1118-23.
71. Bommelaer G, Poynard T, Le Pen C, et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 2004;28:554-61.
72. Caballero-Plasencia AM, Sofos-Kontoyannis S, Valenzuela-Barranco M, et al. Irritable bowel syndrome in patients with dyspepsia: A community-based study in southern Europe. Eur J Gastroenterol Hepatol 1999;11:517-22.
73. Dapoigny M, Bellanger J, Bonaz B, et al. Irritable bowel syndrome in France: A common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 2004;16:995-1001.
74. Gómez Alvarez DF, Morales Vargas JG, Rojas Medina LM, et al. [Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia]. Gastroenterol Hepatol 2009;32:395-400.
75. Olmos JA, iantorno G, Guzmán M, et al. Irritable bowel syndrome: prevalence, comorbidity and impact. A population based study. Gut 2010;59(Suppl III):A361.
76. Iade B, Toma R. Frecuencia del síndrome de intestino irritable en una población de montevideo. Arch Med Int 2003;XXV:91-6.
77. Madrid-Silva AM, Defilippi-Caffri C, Landskron-Ramos G, et al. [The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile]. Rev Gastroenterol Mex 2013;78:203-10.
78. Olguín F, Madrid AM, Catalá M, et al. Prevalenciia del síndrome de intestino irritable en población mapuche. Gastroenterol latinoam 2009;20:238.
79. Curioso WH, Donaires Mendoza N, Bacilio Zerpa C, et al. [Prevalence and relation of dyspepsia to irritable bowel syndrome in a native community of the Peruvian jungle]. Rev Gastroenterol Peru 2002;22:129-40.
80. Campos Hurtado G, Villareal Menchola J, Cornejo Zapata C, et al. [Prevalence of Mannings symptoms in a Lima upper socioeconomic level population]. Rev Gastroenterol Peru 2001;21:301-5.
81. Valerio-Urena J, Vásquez-Fernández F, Jiménez-Pineda A, et al. Prevalencia del sindrome de intestino irritable en población abierta de la ciudad de Veracruz, México. Rev Gastroenterol Mex. 2010;75:36-41.
82. Sander G, Francesconi CF, Mazzoleni LE, et al. Brazilian prevalence of irritable bowel syndrome: A population-based study. Gastroenterology 2008;134(Suppl. 1):A-217.
83. Soares RL, dos Santos JM, Rocha VR. Prevalence of irritable bowel syndrome in a Brazilian Amazon community. Neurogastroenterol Motil 2005;17:883.
84. López-Colombo A, Morgan D, Bravo-González D, et al. The epidemiology of functional gastrointestinal disorders in Mexico: A population-based study. Gastroenterol Res Pract 2012;2012:606174.
85. Schmulson M, Adeyemo M, Gutiérrez-Reyes G, et al. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-32.
86. Schmulson M, Lopez-Colombo A, Mendoza-Gomez A, et al. The Rome III Adult Questionnaire in Spanish-Mexico has a low sensitivity for identifying IBS and higher sensitivity for uninvestigated dyspepsia. Gastroenterology 2012;143(Suppl 1):S-829.
87. Veitia G, Gledhill T, Pernalete B, et al. Prevalencia del sindrome intenstino irritable en la poblacion adulta venezolana. Revista de la Sociedad Venezolana de Gastroenterogica 2011;65:266.
88. Morgan DR, Benshoff M, Cáceres M, et al. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract 2012;2012:343812.
89. Okeke EN, Ladep NG, Adah S, et al. Prevalence of irritable bowel syndrome: A community survey in an African population. Ann Afr Med 2009;8:177-80.
90. Yilmaz S, Dursun M, Ertem M, et al. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: A stratified randomised community-based study. Int J Clin Pract 2005;59:361-9.
91. Celebi S, Acik Y, Deveci SE, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society. J Gastroenterol Hepatol 2004;19:738-43.
92. Sperber AD, Shvartzman P, Friger M, et al. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 2005;17:207-11.
93. Sperber AD, Friger M, Shvartzman P, et al. Rates of functional bowel disorders among Israeli Bedouins in rural areas compared with those who moved to permanent towns. Clin Gastroenterol Hepatol 2005;3:342-8.
94. Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, et al. Irritable bowel syndrome: A population based study. J Gastrointestin Liver Dis 2009;18:413-18.
95. Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol 2003;22:215-6.
96. Khademolhosseini F, Mehrabani D, Nejabat M, et al. Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors. J Res Med Sci 2011;16:200-6.
97. Schmulson M, Ortíz O, Santiago-Lomeli M, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico City. Dig Dis 2006;24:342-7.
98. Miwa H. Life style in persons with functional gastrointestinal disorders-large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil 2012;24:464-71, e217.
99. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525-37.
100. Sperber AD, DeVellis RF, Boehlecke B. Cross-cultural translation: methodology and validation. Journal of Cross-Cultural Psychology 1994;25:501-24.
101. Sperber AD. Translation and validation of study instruments for cross-cultural research. Gastroenterology 2004;126:S124-8.
102. Olubuyide IO, Olawuyi F, Fasanmade AA. A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci 1995;40:983-5.
103. Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol 2008;27:22-8.
104. Ghoshal UC, Abraham P, Bhatia SJ, et al. Comparison of Manning, Rome I, II, III, and Asian diagnostic criteria: Report of a multi-centric Indian irritable bowel syndrome (MIIBS) study. Indian J Gastroenterol 2013;32:369-75.
105. Srivastava D, Ghoshal U, Mittal RD, et al. Associations between IL-1RA polymorphisms and small intestinal bacterial overgrowth among patients with irritable bowel syndrome from India. Neurogastroenterol Motil 2014;26:1408-16.